Skip to main content
. Author manuscript; available in PMC: 2012 Jul 12.
Published in final edited form as: J Immunol. 2009 Apr 1;182(7):4226–4236. doi: 10.4049/jimmunol.0800771

Figure 3. Individual TMPD-induced lipogranulomas contain distinctive populations of B cells.

Figure 3

A, pooled forward primers (VHF1-8) and consensus reverse primer (VHR2) used for amplifying cDNA from lipogranulomas. B, H-chains recovered from lipogranulomas obtained from TMPD-treated BALB/c mice. Lipogranulomas #137, 139, and 140 were isolated from the same mouse. Lipogranulomas #190 and 193 were from a second mouse and lipogranulomas #201 and 204 from a third mouse. C, H-chains recovered from two lipogranulomas (#149 and 150) obtained from a mineral oil-treated BALB/c mouse.

HHS Vulnerability Disclosure